BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
Holders of 5% or more of ONC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BeOne Medicines Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D/A | 7.80%115.9M shares | −0.20 ppfrom 8.00% | Apr 16, 20263 filings | Sep 16, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on BeOne Medicines Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 20264:24 PM ET | Baker Bros. Advisors LPand 4 others | 13D/A | 7.80%115.9M shares | −0.20 ppfrom 8.00% | Sep 14, 2026 | SEC |
| Jun 15, 20264:40 PM ET | Baker Bros. Advisors LPand 4 others | 13D/A | 8.00%115.9M shares | 0.00 ppfrom 8.00% | Jun 11, 2026 | SEC |
| Apr 16, 20264:32 PM ET | Baker Bros. Advisors LPand 4 others | 13D/A | 8.00%115.9M shares | – | Apr 16, 2026 | SEC |
| May 13, 20255:53 PM ET | Capital International Investors | 13G/A | 5.80%81.6M shares | – | Mar 31, 2025 | SEC |
| May 13, 20254:15 PM ET | HHLR Advisors, Ltd.and 1 otherSuperinvestorHHLR Advisors (Hillhouse) | 13D/A | 4.90%68.6M shares | −1.80 ppfrom 6.70%Below 5% | May 9, 2025 | SEC |
| Mar 3, 20259:30 PM ET | HHLR Advisors, Ltd.and 1 otherSuperinvestorHHLR Advisors (Hillhouse) | 13D/A | 6.70%92.8M shares | – | Mar 3, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BeOne Medicines Ltd. shares.
No Form 144 notices for BeOne Medicines Ltd. are on file.